NRG GU006-A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy with or without Enhanced Anti-Androgen Therapy with Apalutamide in Recurrent Prostate Cancer (BALANCE*) *Biomarker trial of ApaLutamide and rAdiation for recurreNt prostate CancEr

January 06, 2020
https://clinicaltrials.gov/ct2/show/NCT03371719
Cancer - Prostate
Principal Investigator: Eleanor M Walker, MD
Prostate cancer, prostate adenocarcinoma, recurrent prostate cancer
Accepting Participants
313-916-8862